Parnell Pharmaceuticals Holdings Ltd Share Price Other OTC
Equities
PARNF
AU0000XINEU9
Pharmaceuticals
Sales 2020 | 30M 20.06M 1.68B | Sales 2021 | 34.17M 22.84M 1.91B | Capitalization | 4.08K 2.73K 228K |
---|---|---|---|---|---|
Net income 2020 | -15M -10.03M -838M | Net income 2021 | -1M -669K -55.85M | EV / Sales 2020 | 2.18 x |
Net Debt 2020 | 56.16M 37.55M 3.14B | Net Debt 2021 | 58.89M 39.38M 3.29B | EV / Sales 2021 | 1.72 x |
P/E ratio 2020 |
-0.56
x | P/E ratio 2021 |
-
| Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Brad R. McCarthy
CEO | Chief Executive Officer | 48 | 01/10/01 |
Joe Rosentel
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
Pablo Lamberto
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jay B. Benear
BRD | Director/Board Member | - | - |
Doug Schillinger
BRD | Director/Board Member | 50 | - |
Eric Moore
BRD | Director/Board Member | - | 21/20/21 |
1st Jan change | Capi. | |
---|---|---|
-12.21% | 79.07B | |
+25.25% | 3.72B | |
+1.95% | 3.33B | |
+18.24% | 1.71B | |
-8.73% | 1.52B | |
-23.19% | 1.29B | |
-2.34% | 1.29B | |
-12.66% | 1.15B | |
+0.24% | 1.05B |